GLAXOSMITHKLINE

GLAXOSMITHKLINE

Displaying 10 out of 16 results

  1. A GSK logo is seen at the GSK research centre in Stevenage

    US FDA declines to approve GSK drugs division's long acting HIV injection

    GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long ...
  2. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    GSK eyes 'step change' in shingles vaccine output in 2024

    GlaxoSmithKline said further growth from its shingles vaccine, which has boosted earnings, would be reined in by limited capacity until 2024, but ...
  3. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    GlaxoSmithKline starts late-stage trial for experimental antibiotic

    GlaxoSmithKline Plc said on Monday it has begun a late-stage study testing its experimental antibiotic in patients with urinary tract infection ...
  4. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    GSK to sell two vaccines in US$1.1 billion deal to focus on newer treatments

    GlaxoSmithKline Plc said on Monday it will sell two travel vaccines to Denmark-based biotechnology company Bavarian Nordic for an upfront payment ...
  5. FILE PHOTO: Zantac heartburn pills are seen in this picture illustration

    GSK recalls popular heartburn drug Zantac globally after cancer scare

    GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "precaution", days after the US Food ...
  6. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    GlaxoSmithKline's cancer therapy cuts risk of disease progression or death by 38per cent

    GlaxoSmithKline plc said on Monday its maintenance therapy for a form of ovarian cancer reduced the risk of disease progression or death by 38per ...